Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.000815217391304379 -0.00190217391304349 -0.00380434782608697 -0.00353260869565224
Stock impact report

GlaxoSmithKline: A Comparative Analysis Of Potential Takeover Targets, Cash Flow And Dividend [Seeking Alpha]

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors
Company Research Source: Seeking Alpha
GlaxoSmithKline: A Comparative Analysis Of Potential Takeover Targets, Cash Flow And DividendSummaryDuring the press release, the new CEO Emma Walmsley was vague about dividends after 2018.At the same time, GlaxoSmithKline seems to be interested in the consumer healthcare division of Pfizer.It is very likely that GSK will cut its dividend in 2019.A dividend cut will both be necessary if the company wants to do acquisitions and healthy for the business.Which possible scenarios are there with regard to acquisition and dividend options for the future? Show less Read more
Impact Snapshot
Event Time:
GSK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for GSK alerts
Opt-in for
GSK alerts

from News Quantified
Opt-in for
GSK alerts

from News Quantified